A citation-based method for searching scientific literature

Alessandra Nerviani, Marie-Astrid Boutet, Wang Sin Gina Tan, Katriona Goldmann, Nirupam Purkayastha, Tamas Ajtos Lajtos, Rebecca Hands, Myles Lewis, Stephen Kelly, Costantino Pitzalis. Ann Rheum Dis 2021
Times Cited: 13







List of co-cited articles
126 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Comparative genomic profiling of synovium versus skin lesions in psoriatic arthritis.
Jennifer Belasco, James S Louie, Nicholas Gulati, Nathan Wei, Kristine Nograles, Judilyn Fuentes-Duculan, Hiroshi Mitsui, Mayte Suárez-Fariñas, James G Krueger. Arthritis Rheumatol 2015
76
53

IL-23 induces spondyloarthropathy by acting on ROR-γt+ CD3+CD4-CD8- entheseal resident T cells.
Jonathan P Sherlock, Barbara Joyce-Shaikh, Scott P Turner, Cheng-Chi Chao, Manjiri Sathe, Jeff Grein, Daniel M Gorman, Edward P Bowman, Terrill K McClanahan, Jennifer H Yearley,[...]. Nat Med 2012
702
46

Guselkumab in biologic-naive patients with active psoriatic arthritis (DISCOVER-2): a double-blind, randomised, placebo-controlled phase 3 trial.
Philip J Mease, Proton Rahman, Alice B Gottlieb, Alexa P Kollmeier, Elizabeth C Hsia, Xie L Xu, Shihong Sheng, Prasheen Agarwal, Bei Zhou, Yanli Zhuang,[...]. Lancet 2020
106
38

Identification of myeloid cells in the human enthesis as the main source of local IL-23 production.
Charlie Bridgewood, Abdulla Watad, Tobias Russell, Timothy M Palmer, Helena Marzo-Ortega, Almas Khan, Peter A Millner, Robert Dunsmuir, Abhay Rao, Peter Loughenbury,[...]. Ann Rheum Dis 2019
46
38

Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis.
Philip J Mease, Iain B McInnes, Bruce Kirkham, Arthur Kavanaugh, Proton Rahman, Désirée van der Heijde, Robert Landewé, Peter Nash, Luminita Pricop, Jiacheng Yuan,[...]. N Engl J Med 2015
495
38

Guselkumab in patients with active psoriatic arthritis who were biologic-naive or had previously received TNFα inhibitor treatment (DISCOVER-1): a double-blind, randomised, placebo-controlled phase 3 trial.
Atul Deodhar, Philip S Helliwell, Wolf-Henning Boehncke, Alexa P Kollmeier, Elizabeth C Hsia, Ramanand A Subramanian, Xie L Xu, Shihong Sheng, Prasheen Agarwal, Bei Zhou,[...]. Lancet 2020
108
30


Association of synovial tissue polyfunctional T-cells with DAPSA in psoriatic arthritis.
Sarah M Wade, Mary Canavan, Trudy McGarry, Candice Low, Siobhan C Wade, Ronan H Mullan, Douglas J Veale, Ursula Fearon. Ann Rheum Dis 2019
39
30

Polyfunctional, Proinflammatory, Tissue-Resident Memory Phenotype and Function of Synovial Interleukin-17A+CD8+ T Cells in Psoriatic Arthritis.
Kathryn J A Steel, Ushani Srenathan, Michael Ridley, Lucy E Durham, Shih-Ying Wu, Sarah E Ryan, Catherine D Hughes, Estee Chan, Bruce W Kirkham, Leonie S Taams. Arthritis Rheumatol 2020
47
30

Single-cell sequencing reveals clonal expansions of pro-inflammatory synovial CD8 T cells expressing tissue-homing receptors in psoriatic arthritis.
Frank Penkava, Martin Del Castillo Velasco-Herrera, Matthew D Young, Nicole Yager, Lilian N Nwosu, Arthur G Pratt, Alicia Lledo Lara, Charlotte Guzzo, Ash Maroof, Lira Mamanova,[...]. Nat Commun 2020
51
30

Psoriatic Arthritis.
Christopher T Ritchlin, Robert A Colbert, Dafna D Gladman. N Engl J Med 2017
603
30


HLA associations reveal genetic heterogeneity in psoriatic arthritis and in the psoriasis phenotype.
Robert Winchester, Gregory Minevich, Valeria Steshenko, Brian Kirby, David Kane, David A Greenberg, Oliver FitzGerald. Arthritis Rheum 2012
147
30

EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update.
Laure Gossec, Xenofon Baraliakos, Andreas Kerschbaumer, Maarten de Wit, Iain McInnes, Maxime Dougados, Jette Primdahl, Dennis G McGonagle, Daniel Aletaha, Andra Balanescu,[...]. Ann Rheum Dis 2020
295
23

Secukinumab versus adalimumab for treatment of active psoriatic arthritis (EXCEED): a double-blind, parallel-group, randomised, active-controlled, phase 3b trial.
Iain B McInnes, Frank Behrens, Philip J Mease, Arthur Kavanaugh, Christopher Ritchlin, Peter Nash, Jordi Gratacós Masmitja, Philippe Goupille, Tatiana Korotaeva, Alice B Gottlieb,[...]. Lancet 2020
88
23

Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial.
Iain B McInnes, Arthur Kavanaugh, Alice B Gottlieb, Lluís Puig, Proton Rahman, Christopher Ritchlin, Carrie Brodmerkel, Shu Li, Yuhua Wang, Alan M Mendelsohn,[...]. Lancet 2013
525
23

Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial.
Peter Nash, Bruce Kirkham, Masato Okada, Proton Rahman, Benard Combe, Gerd-Ruediger Burmester, David H Adams, Lisa Kerr, Chin Lee, Catherine L Shuler,[...]. Lancet 2017
224
23

Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis.
Laura C Coates, Arthur Kavanaugh, Philip J Mease, Enrique R Soriano, Maria Laura Acosta-Felquer, April W Armstrong, Wilson Bautista-Molano, Wolf-Henning Boehncke, Willemina Campbell, Alberto Cauli,[...]. Arthritis Rheumatol 2016
533
23

Role of Th17 cells in human autoimmune arthritis.
Jan Leipe, Mathias Grunke, Claudia Dechant, Christiane Reindl, Ulrike Kerzendorf, Hendrik Schulze-Koops, Alla Skapenko. Arthritis Rheum 2010
329
23

Synovial histopathology of psoriatic arthritis, both oligo- and polyarticular, resembles spondyloarthropathy more than it does rheumatoid arthritis.
Elli Kruithof, Dominique Baeten, Leen De Rycke, Bernard Vandooren, Dirk Foell, Johannes Roth, Juan D Cañete, Annemieke M Boots, Eric M Veys, Filip De Keyser. Arthritis Res Ther 2005
182
23

HLA-C*06:02 genotype is a predictive biomarker of biologic treatment response in psoriasis.
Nick Dand, Michael Duckworth, David Baudry, Alice Russell, Charles J Curtis, Sang Hyuck Lee, Ian Evans, Kayleigh J Mason, Ali Alsharqi, Gabrielle Becher,[...]. J Allergy Clin Immunol 2019
72
23

Role of the IL-23/IL-17 Axis in Psoriasis and Psoriatic Arthritis: The Clinical Importance of Its Divergence in Skin and Joints.
Marie-Astrid Boutet, Alessandra Nerviani, Gabriele Gallo Afflitto, Costantino Pitzalis. Int J Mol Sci 2018
91
23

Preventing psoriatic arthritis: focusing on patients with psoriasis at increased risk of transition.
Jose U Scher, Alexis Ogdie, Joseph F Merola, Christopher Ritchlin. Nat Rev Rheumatol 2019
116
23

Interleukin-17+CD8+ T cells are enriched in the joints of patients with psoriatic arthritis and correlate with disease activity and joint damage progression.
Bina Menon, Nicola J Gullick, Gina J Walter, Megha Rajasekhar, Toby Garrood, Hayley G Evans, Leonie S Taams, Bruce W Kirkham. Arthritis Rheumatol 2014
174
23

Applying precision medicine to unmet clinical needs in psoriatic disease.
Deepak R Jadon, Carmel Stober, Stephen R Pennington, Oliver FitzGerald. Nat Rev Rheumatol 2020
15
23

Complexities in Genetics of Psoriatic Arthritis.
Sara Rahmati, Lam Tsoi, Darren O'Rielly, Vinod Chandran, Proton Rahman. Curr Rheumatol Rep 2020
12
25

Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production.
Frank O Nestle, Curdin Conrad, Adrian Tun-Kyi, Bernhard Homey, Michael Gombert, Onur Boyman, Günter Burg, Yong-Jun Liu, Michel Gilliet. J Exp Med 2005
784
23

The Incidence and Risk Factors for Psoriatic Arthritis in Patients With Psoriasis: A Prospective Cohort Study.
Lihi Eder, Amir Haddad, Cheryl F Rosen, Ker-Ai Lee, Vinod Chandran, Richard Cook, Dafna D Gladman. Arthritis Rheumatol 2016
121
23

Increased frequency of activated CD8+ T cell effectors in patients with psoriatic arthritis.
Marco Diani, Fabio Casciano, Laura Marongiu, Matteo Longhi, Andrea Altomare, Paolo D Pigatto, Paola Secchiero, Roberto Gambari, Giuseppe Banfi, Angelo A Manfredi,[...]. Sci Rep 2019
29
23


Genome-wide Association Analysis of Psoriatic Arthritis and Cutaneous Psoriasis Reveals Differences in Their Genetic Architecture.
Philip E Stuart, Rajan P Nair, Lam C Tsoi, Trilokraj Tejasvi, Sayantan Das, Hyun Min Kang, Eva Ellinghaus, Vinod Chandran, Kristina Callis-Duffin, Robert Ike,[...]. Am J Hum Genet 2015
184
23

On the heritability of psoriatic arthritis. Disease concordance among monozygotic and dizygotic twins.
O B Pedersen, A J Svendsen, L Ejstrup, A Skytthe, P Junker. Ann Rheum Dis 2008
55
23

Proof of concept: enthesitis and new bone formation in spondyloarthritis are driven by mechanical strain and stromal cells.
Peggy Jacques, Stijn Lambrecht, Eveline Verheugen, Elin Pauwels, George Kollias, Maria Armaka, Marleen Verhoye, Annemie Van der Linden, Rik Achten, Rik J Lories,[...]. Ann Rheum Dis 2014
252
23

Prostaglandin E2 synergistically with interleukin-23 favors human Th17 expansion.
Carlo Chizzolini, Rachel Chicheportiche, Montserrat Alvarez, Casimir de Rham, Pascale Roux-Lombard, Sylvie Ferrari-Lacraz, Jean-Michel Dayer. Blood 2008
175
23

Evidence that tissue resident human enthesis γδT-cells can produce IL-17A independently of IL-23R transcript expression.
Richard James Cuthbert, Abdulla Watad, Evangelos M Fragkakis, Robert Dunsmuir, Peter Loughenbury, Almas Khan, Peter A Millner, Adam Davison, Helena Marzo-Ortega, Darren Newton,[...]. Ann Rheum Dis 2019
71
23

Dense genotyping of immune-related susceptibility loci reveals new insights into the genetics of psoriatic arthritis.
John Bowes, Ashley Budu-Aggrey, Ulrike Huffmeier, Steffen Uebe, Kathryn Steel, Harry L Hebert, Chris Wallace, Jonathan Massey, Ian N Bruce, James Bluett,[...]. Nat Commun 2015
116
23

Distinct fibroblast subsets drive inflammation and damage in arthritis.
Adam P Croft, Joana Campos, Kathrin Jansen, Jason D Turner, Jennifer Marshall, Moustafa Attar, Loriane Savary, Corinna Wehmeyer, Amy J Naylor, Samuel Kemble,[...]. Nature 2019
318
23

A head-to-head comparison of the efficacy and safety of ixekizumab and adalimumab in biological-naïve patients with active psoriatic arthritis: 24-week results of a randomised, open-label, blinded-assessor trial.
Philip J Mease, Josef S Smolen, Frank Behrens, Peter Nash, Soyi Liu Leage, Lingnan Li, Hasan Tahir, Melinda Gooderham, Eswar Krishnan, Hong Liu-Seifert,[...]. Ann Rheum Dis 2020
112
15


Bimekizumab in patients with active psoriatic arthritis: results from a 48-week, randomised, double-blind, placebo-controlled, dose-ranging phase 2b trial.
Christopher T Ritchlin, Arthur Kavanaugh, Joseph F Merola, Georg Schett, Jose U Scher, Richard B Warren, Alice B Gottlieb, Deepak Assudani, Kathy Bedford-Rice, Jason Coarse,[...]. Lancet 2020
70
15

European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update.
L Gossec, J S Smolen, S Ramiro, M de Wit, M Cutolo, M Dougados, P Emery, R Landewé, S Oliver, D Aletaha,[...]. Ann Rheum Dis 2016
586
15

Tofacitinib or Adalimumab versus Placebo for Psoriatic Arthritis.
Philip Mease, Stephen Hall, Oliver FitzGerald, Désirée van der Heijde, Joseph F Merola, Francisco Avila-Zapata, Dorota Cieślak, Daniela Graham, Cunshan Wang, Sujatha Menon,[...]. N Engl J Med 2017
268
15

Effective treatment of psoriasis with etanercept is linked to suppression of IL-17 signaling, not immediate response TNF genes.
Lisa C Zaba, Mayte Suárez-Fariñas, Judilyn Fuentes-Duculan, Kristine E Nograles, Emma Guttman-Yassky, Irma Cardinale, Michelle A Lowes, James G Krueger. J Allergy Clin Immunol 2009
239
15

Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial.
Frances Humby, Patrick Durez, Maya H Buch, Myles J Lewis, Hasan Rizvi, Felice Rivellese, Alessandra Nerviani, Giovanni Giorli, Arti Mahto, Carlomaurizio Montecucco,[...]. Lancet 2021
60
15

Ixekizumab, an interleukin-17A specific monoclonal antibody, for the treatment of biologic-naive patients with active psoriatic arthritis: results from the 24-week randomised, double-blind, placebo-controlled and active (adalimumab)-controlled period of the phase III trial SPIRIT-P1.
Philip J Mease, Désirée van der Heijde, Christopher T Ritchlin, Masato Okada, Raquel S Cuchacovich, Catherine L Shuler, Chen-Yen Lin, Daniel K Braun, Chin H Lee, Dafna D Gladman. Ann Rheum Dis 2017
313
15

Effects of ustekinumab versus tumor necrosis factor inhibition on enthesitis: Results from the enthesial clearance in psoriatic arthritis (ECLIPSA) study.
Elizabeth G Araujo, Matthias Englbrecht, Sabrina Hoepken, Stephanie Finzel, Eleni Kampylafka, Arnd Kleyer, Sarah Bayat, Verena Schoenau, Axel Hueber, Juergen Rech,[...]. Semin Arthritis Rheum 2019
65
15

A prospective, randomised, placebo-controlled study to identify biomarkers associated with active treatment in psoriatic arthritis: effects of adalimumab treatment on synovial tissue.
A W R van Kuijk, D M Gerlag, K Vos, G Wolbink, M de Groot, M A de Rie, A H Zwinderman, B A C Dijkmans, P P Tak. Ann Rheum Dis 2009
74
15

Anti-LL37 Antibodies Are Present in Psoriatic Arthritis (PsA) Patients: New Biomarkers in PsA.
Loredana Frasca, Raffaella Palazzo, Maria S Chimenti, Stefano Alivernini, Barbara Tolusso, Laura Bui, Elisabetta Botti, Alessandro Giunta, Luca Bianchi, Luca Petricca,[...]. Front Immunol 2018
51
15

The Genetics of Psoriasis and Psoriatic Arthritis.
Darren D O'Rielly, Meghna Jani, Proton Rahman, James T Elder. J Rheumatol Suppl 2019
26
15



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.